+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Grade Polyglycolic Acid Market - Global Forecast 2026-2032- Product Image
Medical Grade Polyglycolic Acid Market - Global Forecast 2026-2032- Product Image
Sale

Medical Grade Polyglycolic Acid Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283201
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical-Grade Polyglycolic Acid: Executive Overview

Medical-grade polyglycolic acid (PGA) is a biodegradable synthetic polymer used in absorbable sutures, tissue-engineering scaffolds, drug-delivery systems, and selected resorbable medical devices. Its clinical relevance derives from hydrolytic degradation, established processability, and the ability to support temporary mechanical or structural functions before being eliminated from the body. Adoption is shaped by biocompatibility requirements, sterilization performance, degradation behavior, regulatory evidence, and consistency of medical-grade manufacturing.

How Biodegradable Polymer Requirements Are Reshaping Medical Materials

The landscape is shifting toward materials that combine predictable resorption with application-specific mechanical performance. Medical-device developers are placing greater emphasis on controlled molecular weight, impurity reduction, surface characteristics, and degradation profiles that align with healing timelines. This is encouraging more specialized formulations, multilayer structures, copolymer approaches, and tighter process controls rather than reliance on a single material specification.

Regulatory scrutiny is also moving beyond basic biocompatibility toward lifecycle evidence, including degradation products, sterilization effects, manufacturing traceability, and performance after processing. These requirements favor suppliers and device developers able to connect polymer chemistry with validated clinical use and reproducible quality systems.

Artificial Intelligence Is Strengthening Polymer Development and Quality Control

Artificial intelligence can accelerate medical-grade PGA development by linking formulation variables, processing conditions, degradation behavior, and device performance across large experimental datasets. Predictive models may help prioritize polymer architectures, extrusion or molding parameters, sterilization conditions, and release profiles before physical testing, reducing inefficient iteration while preserving laboratory and regulatory validation.

In manufacturing, machine-learning tools can support anomaly detection in molecular-weight distribution, thermal behavior, dimensional accuracy, and visual inspection. AI can also improve documentation workflows, supplier-risk screening, and post-market signal analysis. These applications do not replace validated analytical methods or human quality oversight; they add value when datasets are traceable, models are governed, and outputs remain auditable under medical-device quality systems.

Regional Insights: Regulation, Manufacturing, and Clinical Adoption Differ

North America combines advanced medical-device development with stringent regulatory and quality expectations, supporting demand for well-characterized absorbable materials. Europe places strong emphasis on conformity assessment, chemical safety, traceability, and circularity considerations, while European clinical and industrial networks support development of resorbable devices. Asia-Pacific includes major polymer and medical-manufacturing capabilities, with Japan, China, South Korea, Australia, and India presenting distinct regulatory, clinical, and production environments.

Latin America is influenced by import requirements, healthcare-access priorities, and local device-manufacturing capacity. The Middle East is developing specialized healthcare infrastructure and depends substantially on validated international supply chains, particularly in the GCC. Africa presents varied access conditions, regulatory maturity, and clinical infrastructure; applications with clear procedural value and dependable distribution are more likely to progress. Across all regions, sterilization compatibility, documentation, and reliable supply remain central adoption conditions.

Group Insights: Trade, Regulation, and Industrial Coordination Shape Access

ASEAN markets reflect diverse regulatory systems and manufacturing capabilities, making harmonized documentation and regional supply-chain coordination important. BRICS economies include substantial polymer, pharmaceutical, and medical-device capabilities, but differ in reimbursement, regulatory pathways, and domestic production priorities. The European Union benefits from regulatory alignment and integrated industrial networks, although compliance requirements can be demanding.

G7 economies generally combine advanced clinical research, mature quality systems, and sophisticated device engineering. GCC markets are characterized by concentrated healthcare investment, procurement sensitivity, and reliance on international validation. NATO countries span multiple regulatory jurisdictions but collectively include strong medical-technology, defense-medical, and research infrastructures. These groupings are useful for assessing standards alignment, procurement behavior, and resilience rather than treating them as uniform commercial markets.

Country Insights: Distinct Regulatory and Manufacturing Priorities

Australia emphasizes evidence-based healthcare, regulated devices, and dependable imported or locally supported supply chains. Brazil and Mexico combine sizable healthcare systems with evolving domestic manufacturing and regulatory requirements. Canada and the United States provide advanced clinical, research, and device-development environments, with high expectations for quality documentation and risk management.

China, India, Japan, and South Korea have important chemical, polymer, electronics, pharmaceutical, or medical-device capabilities, but each applies distinct approval, localization, and quality-system expectations. France, Germany, Italy, Spain, and the United Kingdom contribute strong clinical, engineering, and regulatory expertise within different national and regional frameworks. Russia presents a distinct operating environment shaped by domestic industrial priorities, procurement conditions, and international trade constraints. Across these countries, successful adoption depends on application-specific validation, dependable raw-material controls, and regulatory alignment.

Actions for Leaders: Build Validated, Resilient, Application-Specific Platforms

Industry leaders should define PGA specifications around clinical use rather than commodity polymer attributes. Priority actions include validating degradation and sterilization behavior for each device design, controlling molecular-weight and impurity profiles, documenting material traceability, and generating evidence that links processing conditions to clinical performance.

Organizations should also diversify qualified suppliers, establish contingency plans for critical intermediates and testing services, and engage regulators early when introducing new architectures or delivery systems. AI can be deployed selectively for formulation screening, process monitoring, and document review, provided governance includes validated datasets, change control, cybersecurity, and human approval. Partnerships with clinical institutions and specialized manufacturers can further reduce translation risk while preserving quality-system compliance.

Research Methodology: Evidence-Based Assessment of Medical-Grade PGA

This executive summary uses a structured review of the medical-grade PGA value chain, including polymer properties, medical applications, manufacturing considerations, regulatory expectations, clinical-use requirements, and regional operating conditions. The analysis distinguishes established uses from emerging applications and evaluates adoption drivers through technical, quality, regulatory, and supply-chain lenses.

Regional, group, and country comparisons are framed around documented healthcare infrastructure, industrial capabilities, regulatory structures, trade conditions, and research activity. Claims are limited to verifiable qualitative insights; no market estimates, market shares, forecasts, or company-specific assessments are included. AI-related observations describe validated potential applications and recognize that implementation requires quality-system controls and independent technical verification.

Conclusion: Reliable Degradation and Quality Discipline Define Competitive Readiness

Medical-grade PGA remains relevant where temporary support, predictable biodegradation, and processable medical materials are clinically valuable. Its advancement depends less on polymer availability alone than on the ability to deliver consistent specifications, validated degradation behavior, sterilization compatibility, and complete regulatory evidence.

Leaders that align material science, device engineering, manufacturing quality, regional compliance, and resilient sourcing will be better positioned to translate PGA into dependable clinical products. Artificial intelligence can strengthen this pathway, but only when integrated with sound experimentation, traceable data, and human-led validation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Grade Polyglycolic Acid Market, by Product Form
7.1. Introduction
7.2. PGA Resin / Pellets
7.3. PGA Fibers
7.4. PGA Sutures & Filaments
8. Medical Grade Polyglycolic Acid Market, by Molecular Weight
8.1. Introduction
8.2. Low Molecular Weight PGA
8.3. Medium Molecular Weight PGA
8.4. High Molecular Weight PGA
9. Medical Grade Polyglycolic Acid Market, by Implantability
9.1. Introduction
9.2. Implantable Grade PGA
9.3. Non-Implantable Medical Grade PGA
10. Medical Grade Polyglycolic Acid Market, by End User
10.1. Introduction
10.2. Hospitals & Surgical Centers
10.3. Medical Device Manufacturers
11. Medical Grade Polyglycolic Acid Market, by Application
11.1. Introduction
11.2. Absorbable Surgical Sutures
11.3. Orthopedic Fixation Devices
11.4. Tissue Engineering Scaffolds
12. Medical Grade Polyglycolic Acid Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Medical Grade Polyglycolic Acid Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Medical Grade Polyglycolic Acid Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Advanced Medical Solutions Group PLC
16.2. BASF SE
16.3. Bayer AG
16.4. BMG Incorporated
16.5. Corbion NV
16.6. Danhua Chemical Technology Co., Ltd.
16.7. DuPont de Nemours, Inc.
16.8. Evonik Industries AG
16.9. Huizhou Foryou Medical Device Co., Ltd.
16.10. Kureha Corporation
16.11. Lotus Surgicals Pvt. Ltd.
16.12. Meta Biomed Co., Ltd.
16.13. Polysciences, Inc.
16.14. Samyang Biopharm Corporation
16.15. Shanghai Pujing Chemical Industry Co., Ltd.
16.16. Shenzhen Polymtek Biomaterial Co., Ltd.
16.17. Teleflex Incorporated
16.18. Tepha Inc.
16.19. Toray Industries, Inc.
16.20. Unisur Lifecare Pvt. Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medical Grade Polyglycolic Acid Market, Years Considered for the Study
FIGURE 2. Global Medical Grade Polyglycolic Acid Market, Research Design
FIGURE 3. Global Medical Grade Polyglycolic Acid Market, Research Framework
FIGURE 4. Global Medical Grade Polyglycolic Acid Market, Data Triangulation
FIGURE 5. Global Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medical Grade Polyglycolic Acid Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 7. Global Medical Grade Polyglycolic Acid Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2025 vs 2032 (%)
FIGURE 9. Global Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medical Grade Polyglycolic Acid Market Size, by Implantability, 2025 vs 2032 (%)
FIGURE 11. Global Medical Grade Polyglycolic Acid Market Size, by Implantability, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medical Grade Polyglycolic Acid Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Medical Grade Polyglycolic Acid Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medical Grade Polyglycolic Acid Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Medical Grade Polyglycolic Acid Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medical Grade Polyglycolic Acid Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Medical Grade Polyglycolic Acid Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Medical Grade Polyglycolic Acid Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medical Grade Polyglycolic Acid Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Medical Grade Polyglycolic Acid Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Medical Grade Polyglycolic Acid Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medical Grade Polyglycolic Acid Market Segmentation & Coverage
TABLE 2. Global Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 4. Global PGA Resin / Pellets Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global PGA Resin / Pellets Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global PGA Resin / Pellets Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global PGA Fibers Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global PGA Fibers Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global PGA Fibers Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global PGA Sutures & Filaments Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global PGA Sutures & Filaments Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global PGA Sutures & Filaments Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 14. Global Low Molecular Weight PGA Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Low Molecular Weight PGA Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Low Molecular Weight PGA Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Medium Molecular Weight PGA Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Medium Molecular Weight PGA Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Medium Molecular Weight PGA Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global High Molecular Weight PGA Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global High Molecular Weight PGA Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global High Molecular Weight PGA Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 24. Global Implantable Grade PGA Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Implantable Grade PGA Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Implantable Grade PGA Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Non-Implantable Medical Grade PGA Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Non-Implantable Medical Grade PGA Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Non-Implantable Medical Grade PGA Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 31. Global Hospitals & Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Hospitals & Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Hospitals & Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Medical Device Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Medical Device Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Medical Device Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 38. Global Absorbable Surgical Sutures Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Absorbable Surgical Sutures Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Absorbable Surgical Sutures Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Orthopedic Fixation Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Orthopedic Fixation Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Orthopedic Fixation Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Tissue Engineering Scaffolds Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Tissue Engineering Scaffolds Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Tissue Engineering Scaffolds Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Medical Grade Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Medical Grade Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 54. North America Medical Grade Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. North America Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 56. North America Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 57. North America Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 58. North America Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. North America Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 60. Latin America Medical Grade Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Latin America Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 62. Latin America Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 63. Latin America Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 64. Latin America Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Latin America Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 66. Europe Medical Grade Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Europe Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 68. Europe Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 69. Europe Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 70. Europe Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Europe Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 72. Middle East Medical Grade Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Middle East Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 74. Middle East Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 75. Middle East Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 76. Middle East Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Middle East Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 78. Africa Medical Grade Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Africa Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 80. Africa Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 81. Africa Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 82. Africa Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Africa Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Global Medical Grade Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. ASEAN Medical Grade Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. ASEAN Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 87. ASEAN Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 88. ASEAN Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 89. ASEAN Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. ASEAN Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. GCC Medical Grade Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. GCC Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 93. GCC Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 94. GCC Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 95. GCC Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. GCC Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. European Union Medical Grade Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. European Union Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 99. European Union Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 100. European Union Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 101. European Union Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. European Union Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. BRICS Medical Grade Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. BRICS Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 105. BRICS Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 106. BRICS Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 107. BRICS Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. BRICS Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. G7 Medical Grade Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. G7 Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 111. G7 Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 112. G7 Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 113. G7 Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. G7 Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. NATO Medical Grade Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. NATO Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 117. NATO Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 118. NATO Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 119. NATO Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. NATO Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Global Medical Grade Polyglycolic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. United States Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 123. United States Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 124. United States Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 125. United States Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 126. United States Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. United States Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Canada Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 129. Canada Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 130. Canada Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 131. Canada Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 132. Canada Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Canada Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Mexico Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 135. Mexico Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 136. Mexico Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 137. Mexico Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 138. Mexico Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Mexico Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. Brazil Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 141. Brazil Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 142. Brazil Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 143. Brazil Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 144. Brazil Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Brazil Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. United Kingdom Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 147. United Kingdom Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 148. United Kingdom Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 149. United Kingdom Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 150. United Kingdom Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. United Kingdom Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. Germany Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 153. Germany Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 154. Germany Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 155. Germany Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 156. Germany Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Germany Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. France Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 159. France Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 160. France Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 161. France Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 162. France Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. France Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. Russia Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 165. Russia Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 166. Russia Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 167. Russia Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 168. Russia Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Russia Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Italy Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 171. Italy Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 172. Italy Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 173. Italy Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 174. Italy Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Italy Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Spain Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 177. Spain Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 178. Spain Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 179. Spain Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 180. Spain Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Spain Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. China Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 183. China Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 184. China Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 185. China Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 186. China Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. China Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. India Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 189. India Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 190. India Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 191. India Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 192. India Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. India Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. Japan Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 195. Japan Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 196. Japan Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 197. Japan Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 198. Japan Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Japan Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Australia Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 201. Australia Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 202. Australia Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 203. Australia Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 204. Australia Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Australia Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. South Korea Medical Grade Polyglycolic Acid Market Size, 2017-2032 (USD Million)
TABLE 207. South Korea Medical Grade Polyglycolic Acid Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 208. South Korea Medical Grade Polyglycolic Acid Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 209. South Korea Medical Grade Polyglycolic Acid Market Size, by Implantability, 2017-2032 (USD Million)
TABLE 210. South Korea Medical Grade Polyglycolic Acid Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. South Korea Medical Grade Polyglycolic Acid Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. Global Medical Grade Polyglycolic Acid Market Share, by Key Player, 2025
TABLE 213. Global Medical Grade Polyglycolic Acid Market, Key Experts

Companies Mentioned

  • Advanced Medical Solutions Group PLC
  • BASF SE
  • Bayer AG
  • BMG Incorporated
  • Corbion NV
  • Danhua Chemical Technology Co., Ltd.
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Huizhou Foryou Medical Device Co., Ltd.
  • Kureha Corporation
  • Lotus Surgicals Pvt. Ltd.
  • Meta Biomed Co., Ltd.
  • Polysciences, Inc.
  • Samyang Biopharm Corporation
  • Shanghai Pujing Chemical Industry Co., Ltd.
  • Shenzhen Polymtek Biomaterial Co., Ltd.
  • Teleflex Incorporated
  • Tepha Inc.
  • Toray Industries, Inc.
  • Unisur Lifecare Pvt. Ltd.

Related Topics

Related Reports

Polyglycolic Acid Market - Global Forecast 2026-2032 - Product Image

Polyglycolic Acid Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Fully Biodegradable Polyglycolic Acid Market - Global Forecast 2026-2032 - Product Image

Fully Biodegradable Polyglycolic Acid Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Industrial Polyglycolic Acid Market - Global Forecast 2026-2032 - Product Image

Industrial Polyglycolic Acid Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Polyglycolic Acid Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Polyglycolic Acid Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Polyglycolic Acid Market in Canada - Product Image

Polyglycolic Acid Market in Canada

  • Report
  • 152 Pages
  • Canada
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.